Haoxi Health (HAO) CEO Fan Zhen buys 40M Class B shares in open market

Rhea-AI Filing Summary

Haoxi Health Technology Ltd CEO and Chairman Fan Zhen, a ten percent owner, reported an open-market purchase of 40,000,000 Class B Ordinary Shares at $0.018 per share. After this transaction, Fan Zhen directly holds 40,690,800 Class B Ordinary Shares.

Insights

Insider trading analyst

Large open-market share purchase by Haoxi Health’s CEO indicates increased personal exposure.

Fan Zhen, CEO, Chairman, and a ten percent owner of Haoxi Health Technology Ltd, executed an open-market purchase of 40,000,000 Class B Ordinary Shares at $0.018 per share. This is a direct ownership transaction, not through an intermediary entity.

Following the purchase, Fan Zhen’s direct holdings increased to 40,690,800 Class B Ordinary Shares, according to the filing. The transactionSummary characterizes this activity as a single net-buy event, with no derivative exercises, gifts, or tax-withholding components reported in this filing.

There are no remaining derivative positions disclosed in the derivativeSummary for this report, so the visible exposure comes entirely from common equity. Future company filings may clarify how this position compares with total shares outstanding and any additional transactions after May 19, 2026.

Insider Trade Summary

Net Buyer: 40,000,000 shares ($720,000)

Net Buy 1 txn

Insider Fan Zhen

Role CEO & Chairman

Bought 40,000,000 shs ($720K)

Type	Security	Shares	Price	Value
Purchase	Class B Ordinary Shares	40,000,000	$0.018	$720K

Holdings After Transaction: Class B Ordinary Shares — 40,690,800 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 40,000,000 shares Purchase price: $0.018 per share Shares held after transaction: 40,690,800 shares +2 more

5 metrics

Shares purchased 40,000,000 shares Class B Ordinary Shares bought in open market

Purchase price $0.018 per share Price for Class B Ordinary Shares on May 19, 2026

Shares held after transaction 40,690,800 shares Direct Class B Ordinary Share holdings post-transaction

Transaction code P Open-market or private purchase of non-derivative security

Net buy direction 40,000,000 shares net-buy transactionSummary net buy-sell shares

Key Terms

Class B Ordinary Shares, open-market purchase, ten percent owner, Form 4

4 terms

Class B Ordinary Shares financial

"security_title: Class B Ordinary Shares"

Class B ordinary shares are a type of ownership stake in a company that typically come with different voting rights or privileges compared to other share classes. For investors, they represent a way to hold part of the company’s value and influence its decisions, often with fewer voting rights than Class A shares. Understanding these shares helps investors assess their level of control and potential returns within a company.

open-market purchase financial

"transaction_action: open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner regulatory

"is_ten_percent_owner: 1"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fan Zhen

(Last) (First) (Middle)

ROOM 902, UNIT 1, 9TH FLOOR

NO.6A CHAOYANGMENWAI STREET

(Street)

BEIJING 100020

(City) (State) (Zip)

CHINA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Haoxi Health Technology Ltd [ HAO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Ordinary Shares	05/19/2026		P		40,000,000	A	$0.018	40,690,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Fan Zhen	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Haoxi Health Technology (HAO) report on this Form 4?

Haoxi Health Technology reported that CEO and Chairman Fan Zhen bought 40,000,000 Class B Ordinary Shares. The shares were acquired in an open-market purchase at $0.018 per share, increasing his direct holdings to 40,690,800 Class B Ordinary Shares after the transaction.

Who is the insider involved in the recent Haoxi Health (HAO) share purchase?

The insider is Fan Zhen, CEO, Chairman, and a ten percent owner of Haoxi Health Technology Ltd. He completed an open-market purchase of 40,000,000 Class B Ordinary Shares at $0.018 per share, raising his direct ownership to 40,690,800 shares.

How many Haoxi Health (HAO) shares did the CEO hold after the reported transaction?

After the transaction, CEO Fan Zhen directly held 40,690,800 Class B Ordinary Shares. This figure reflects his position immediately following the open-market purchase of 40,000,000 shares at $0.018 per share, as disclosed in the Form 4 filing.

What was the price per share in the Haoxi Health (HAO) insider purchase?

The reported purchase price was $0.018 per Class B Ordinary Share. At this price, CEO and Chairman Fan Zhen acquired 40,000,000 shares in an open-market transaction, substantially increasing his direct holdings to 40,690,800 Class B Ordinary Shares.

Was the Haoxi Health (HAO) insider transaction a buy or sell?

The transaction was a buy, specifically an open-market purchase. Form 4 data classify it with transaction code P, indicating Fan Zhen purchased 40,000,000 Class B Ordinary Shares at $0.018, taking his post-transaction direct holdings to 40,690,800 shares.

Did the Haoxi Health (HAO) Form 4 include any derivative or option exercises?

No derivative or option exercises were reported in this Form 4. The derivativeSummary is empty, and the transactionSummary shows one net-buy event in non-derivative Class B Ordinary Shares, with no exercises, gifts, or tax-withholding transactions disclosed.